US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist

3.380
-0.020-0.59%

Close May 15 16:00 ET

3.360
-0.020-0.59%

Post 17:52 ET

75.09MMarket Cap-1965P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

13.45%-7.19M

11.96%-27.36M

4.69%-6.18M

28.49%-6.49M

24.03%-6.39M

-16.83%-8.3M

-19.71%-31.07M

18.86%-6.48M

23.05%-9.07M

-6,725.20%-8.41M

Net income from continuing operations

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

-29.90%-9.17M

Depreciation and amortization

-29.60%88K

-40.28%381K

-60.83%85K

-56.22%88K

-25.89%83K

15.74%125K

70.59%638K

112.75%217K

87.85%201K

28.74%112K

Other non cash items

0.41%487K

20.00%1.88M

5.57%474K

69.57%468K

-2.77%457K

29.33%485K

6.15%1.57M

20.05%449K

-49.36%276K

11.64%470K

Change In working capital

31.80%-1.18M

-408.41%-2.68M

-122.42%-343K

21.15%-820K

207.18%209K

-400.70%-1.72M

241.60%868K

259.38%1.53M

77.52%-1.04M

-103.11%-195K

-Change in prepaid assets

-35.71%-38K

-78.91%193K

-96.72%41K

72.16%-218K

47.96%398K

-115.73%-28K

611.17%915K

439.02%1.25M

1.76%-783K

-79.88%269K

-Change in payables and accrued expense

33.22%-798K

-185.21%-1.24M

-99.12%5K

-171.05%-81K

14.29%32K

-261.05%-1.2M

139.93%1.45M

328.00%570K

103.27%114K

-99.44%28K

-Change in other current liabilities

32.20%-339K

-8.66%-1.63M

-33.68%-389K

-40.43%-521K

55.08%-221K

-44.09%-500K

-44.33%-1.5M

14.66%-291K

-6.30%-371K

-347.27%-492K

Cash from discontinued investing activities

Operating cash flow

13.45%-7.19M

11.96%-27.36M

4.69%-6.18M

28.49%-6.49M

24.03%-6.39M

-16.83%-8.3M

-19.71%-31.07M

18.86%-6.48M

23.05%-9.07M

-6,725.20%-8.41M

Investing cash flow

Cash flow from continuing investing activities

-265.22%-168K

69.75%-170K

98.03%-7K

-23.16%-117K

-1,433.33%-46K

-479.38%-562K

-1,218.52%-356K

-871.43%-108K

-35.71%-95K

Net PPE purchase and sale

-265.22%-168K

69.75%-170K

98.03%-7K

--0

-23.16%-117K

-1,433.33%-46K

-316.30%-562K

-1,218.52%-356K

-350.00%-108K

-35.71%-95K

Cash from discontinued investing activities

Investing cash flow

-265.22%-168K

69.75%-170K

98.03%-7K

--0

-23.16%-117K

-1,433.33%-46K

-479.38%-562K

-1,218.52%-356K

-871.43%-108K

-35.71%-95K

Financing cash flow

Cash flow from continuing financing activities

922.73%450K

212.22%35.6M

826.81%34.35M

-94.00%21K

-91.74%1.19M

-96.86%44K

-80.69%11.4M

-52,411.11%-4.73M

-88.95%350K

-64.90%14.38M

Net issuance payments of debt

----

--0

----

-131.59%-4.74M

----

Net common stock issuance

475.00%253K

301.78%35.6M

286,141.67%34.35M

-94.02%21K

-83.26%1.19M

-96.86%44K

-73.49%8.86M

124.49%12K

-89.87%351K

-76.36%7.1M

Proceeds from stock option exercised by employees

--197K

--0

----

--0

6,641.67%7.28M

----

Cash from discontinued financing activities

Financing cash flow

922.73%450K

212.22%35.6M

826.81%34.35M

-94.00%21K

-91.74%1.19M

-96.86%44K

-80.69%11.4M

-52,411.11%-4.73M

-88.95%350K

-64.90%14.38M

Net cash flow

Beginning cash position

25.56%39.67M

-39.03%31.6M

-73.34%11.51M

-65.43%17.97M

-49.50%23.29M

-39.03%31.6M

175.39%51.83M

-27.78%43.16M

-24.06%51.99M

68.08%46.12M

Current changes in cash

16.87%-6.9M

139.91%8.08M

343.64%28.17M

26.77%-6.47M

-190.69%-5.32M

-45.52%-8.31M

-161.29%-20.23M

-44.13%-11.56M

-2.58%-8.83M

-85.70%5.87M

End cash Position

40.68%32.77M

25.56%39.67M

-73.34%11.51M

-65.43%17.97M

-49.50%23.29M

-39.03%31.6M

-27.78%43.16M

-24.06%51.99M

Free cash flow

11.92%-7.35M

12.98%-27.53M

9.55%-6.18M

29.34%-6.49M

23.50%-6.51M

-17.43%-8.35M

-21.24%-31.63M

14.69%-6.84M

22.29%-9.18M

-15,028.07%-8.51M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	13.45%-7.19M	11.96%-27.36M	4.69%-6.18M	28.49%-6.49M	24.03%-6.39M	-16.83%-8.3M	-19.71%-31.07M	18.86%-6.48M	23.05%-9.07M	-6,725.20%-8.41M
Net income from continuing operations	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M	-29.90%-9.17M
Depreciation and amortization	-29.60%88K	-40.28%381K	-60.83%85K	-56.22%88K	-25.89%83K	15.74%125K	70.59%638K	112.75%217K	87.85%201K	28.74%112K
Other non cash items	0.41%487K	20.00%1.88M	5.57%474K	69.57%468K	-2.77%457K	29.33%485K	6.15%1.57M	20.05%449K	-49.36%276K	11.64%470K
Change In working capital	31.80%-1.18M	-408.41%-2.68M	-122.42%-343K	21.15%-820K	207.18%209K	-400.70%-1.72M	241.60%868K	259.38%1.53M	77.52%-1.04M	-103.11%-195K
-Change in prepaid assets	-35.71%-38K	-78.91%193K	-96.72%41K	72.16%-218K	47.96%398K	-115.73%-28K	611.17%915K	439.02%1.25M	1.76%-783K	-79.88%269K
-Change in payables and accrued expense	33.22%-798K	-185.21%-1.24M	-99.12%5K	-171.05%-81K	14.29%32K	-261.05%-1.2M	139.93%1.45M	328.00%570K	103.27%114K	-99.44%28K
-Change in other current liabilities	32.20%-339K	-8.66%-1.63M	-33.68%-389K	-40.43%-521K	55.08%-221K	-44.09%-500K	-44.33%-1.5M	14.66%-291K	-6.30%-371K	-347.27%-492K
Cash from discontinued investing activities
Operating cash flow	13.45%-7.19M	11.96%-27.36M	4.69%-6.18M	28.49%-6.49M	24.03%-6.39M	-16.83%-8.3M	-19.71%-31.07M	18.86%-6.48M	23.05%-9.07M	-6,725.20%-8.41M
Investing cash flow
Cash flow from continuing investing activities	-265.22%-168K	69.75%-170K	98.03%-7K	0	-23.16%-117K	-1,433.33%-46K	-479.38%-562K	-1,218.52%-356K	-871.43%-108K	-35.71%-95K
Net PPE purchase and sale	-265.22%-168K	69.75%-170K	98.03%-7K	--0	-23.16%-117K	-1,433.33%-46K	-316.30%-562K	-1,218.52%-356K	-350.00%-108K	-35.71%-95K
Cash from discontinued investing activities
Investing cash flow	-265.22%-168K	69.75%-170K	98.03%-7K	--0	-23.16%-117K	-1,433.33%-46K	-479.38%-562K	-1,218.52%-356K	-871.43%-108K	-35.71%-95K
Financing cash flow
Cash flow from continuing financing activities	922.73%450K	212.22%35.6M	826.81%34.35M	-94.00%21K	-91.74%1.19M	-96.86%44K	-80.69%11.4M	-52,411.11%-4.73M	-88.95%350K	-64.90%14.38M
Net issuance payments of debt	----	--0	----	----	----	----	-131.59%-4.74M	----	----	----
Net common stock issuance	475.00%253K	301.78%35.6M	286,141.67%34.35M	-94.02%21K	-83.26%1.19M	-96.86%44K	-73.49%8.86M	124.49%12K	-89.87%351K	-76.36%7.1M
Proceeds from stock option exercised by employees	--197K	--0	----	----	--0	--0	6,641.67%7.28M	----	----	----
Cash from discontinued financing activities
Financing cash flow	922.73%450K	212.22%35.6M	826.81%34.35M	-94.00%21K	-91.74%1.19M	-96.86%44K	-80.69%11.4M	-52,411.11%-4.73M	-88.95%350K	-64.90%14.38M
Net cash flow
Beginning cash position	25.56%39.67M	-39.03%31.6M	-73.34%11.51M	-65.43%17.97M	-49.50%23.29M	-39.03%31.6M	175.39%51.83M	-27.78%43.16M	-24.06%51.99M	68.08%46.12M
Current changes in cash	16.87%-6.9M	139.91%8.08M	343.64%28.17M	26.77%-6.47M	-190.69%-5.32M	-45.52%-8.31M	-161.29%-20.23M	-44.13%-11.56M	-2.58%-8.83M	-85.70%5.87M
End cash Position	40.68%32.77M	25.56%39.67M	25.56%39.67M	-73.34%11.51M	-65.43%17.97M	-49.50%23.29M	-39.03%31.6M	-39.03%31.6M	-27.78%43.16M	-24.06%51.99M
Free cash flow	11.92%-7.35M	12.98%-27.53M	9.55%-6.18M	29.34%-6.49M	23.50%-6.51M	-17.43%-8.35M	-21.24%-31.63M	14.69%-6.84M	22.29%-9.18M	-15,028.07%-8.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall